presented by Claudia Senesac
Duchenne Muscular Dystrophy (DMD) is the most common childhood muscular dystrophy. Much of what we have known about this disease has been based on years of clinical observation, muscle biopsy, and other limited testing. Longitudinal studies and clinical trials are shaping our “new understanding” of this disease. The courses related to DMD will span pathophysiology, research, the development of therapy recommendations, and quality of life issues. Therapy recommendations are based on predictive models of biomarkers and function helping therapists and families plan for the future. Therapists play a critical role in caring for boys and young men with this disease.
Claudia Senesac is a Clinical Associate professor at University of Florida in the Doctor of Physical Therapy department. Her teaching responsibilities include Functional Anatomy dissection and Pediatrics in Physical Therapy. She has over 37 years of pediatric clinical experience. She has been the owner and administrator of a pediatric physical therapy private practice since 1984 and is a board certified clinical specialist in Pediatrics. Claudia is still providing therapy to children with a variety of conditions. Her research focus has been in Duchenne Muscular Dystrophy (DMD). She is a sub-investigator for a multi-center NIH funded grant investigating Magnetic Resonance Imaging and Biomarkers in boys with Duchenne Muscular Dystrophy. In addition, she has spearheaded investigating the reliability and common errors seen in outcome measures in DMD across research and clinic sites. She is a national educator for Parent Project Muscular Dystrophy translating research to clinical practice. She has several publications in peer reviewed journals related to Duchenne Muscular Dystrophy as author and co-author. Most recently she was the recipient of the International Educator of the Year award for the College of Public Health and Health Professions at UF, 2016, and in 2014 Outstanding Pediatric Clinician Award from the Pediatric Section of the APTA.
In this chapter, the stages of the disease and transitions from one stage to the next will be introduced. Loss of the key functional skills will be discussed as it relates to key large muscle groups.
The early stages of the disease and transitions from pre-symptomatic to middle ambulatory stages. Understanding the impact of disease progression on the patient and family.
After watching this chapter, participants will be able to describe the late stage of walking and the early non-ambulatory stages of DMD. They will also be able to identify critical time periods for intervention.
The chapter will describe the late non-ambulatory stages of DMD and identify critical time periods for intervention. We will also discuss important issues with the family as their child transitions from one stage to the next.
This chapter will identify function vs. impairment based outcomes used in assessing boys with DMD across the lifespan. Learners will also be able to identify and justify the use of appropriate outcomes for ambulatory and non-ambulatory boys with DMD for documentation.
Assessing a patient with DMD through case description. Pulling together the important factors in the development of a plan of care that is individualized based on the results of observation, hands-on evaluation, report, and functional measures. Determining goals derived from the assessment.